Search research articles
Contact Us
Filters
Showing results (81-90 of 169) with videos related to
Page
of 17
Sort By:
Antiviral Research
|
August 26, 2018
Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses
Priya Luthra, Jacinth Naidoo, Colette A Pietzsch, et al.
The Journal of Biological Chemistry
|
June 18, 2014
Role of protein phosphatase 1 in dephosphorylation of Ebola virus VP30 protein and its targeting for the inhibition of viral transcription
Philipp A Ilinykh, Bersabeh Tigabu, Andrey Ivanov, et al.
Research Square
|
June 19, 2023
Ebola Virus NP Binding to Host Protein Phosphatase-1 Regulates Capsid Formation
Asrar Ahmad, Bersabeh Tigabu, Andrey Ivanov, et al.
Plos Pathogens
|
August 24, 2018
Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap
Philipp A Ilinykh, Rodrigo I Santos, Bronwyn M Gunn, et al.
Nature Communications
|
April 19, 2019
Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk
Liam B King, Brandyn R West, Crystal L Moyer, et al.
ACS Infectious Diseases
|
February 4, 2017
A Sensitive in Vitro High-Throughput Screen To Identify Pan-filoviral Replication Inhibitors Targeting the VP35-NP Interface
Gai Liu, Peter J Nash, Britney Johnson, et al.
Nature Communications
|
July 2, 2025
Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses
Michelle Meyer, Bronwyn M Gunn, Colette Pietzsch, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 24, 2020
Discovery of Marburg virus neutralizing antibodies from virus-naïve human antibody repertoires using large-scale structural predictions
Nina G Bozhanova, Amandeep K Sangha, Alexander M Sevy, et al.
Journal of Virology
|
February 5, 2010
Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells
James A Harker, Alexandra Godlee, Jennifer L Wahlsten, et al.
NPJ Vaccines
|
July 23, 2021
A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19
Delphine C Malherbe, Drishya Kurup, Christoph Wirblich, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 169) with videos related to
Sort By:
Page
of 17
Antiviral Research
|
August 26, 2018
Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses
Priya Luthra, Jacinth Naidoo, Colette A Pietzsch, et al.
The Journal of Biological Chemistry
|
June 18, 2014
Role of protein phosphatase 1 in dephosphorylation of Ebola virus VP30 protein and its targeting for the inhibition of viral transcription
Philipp A Ilinykh, Bersabeh Tigabu, Andrey Ivanov, et al.
Research Square
|
June 19, 2023
Ebola Virus NP Binding to Host Protein Phosphatase-1 Regulates Capsid Formation
Asrar Ahmad, Bersabeh Tigabu, Andrey Ivanov, et al.
Plos Pathogens
|
August 24, 2018
Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap
Philipp A Ilinykh, Rodrigo I Santos, Bronwyn M Gunn, et al.
Nature Communications
|
April 19, 2019
Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk
Liam B King, Brandyn R West, Crystal L Moyer, et al.
ACS Infectious Diseases
|
February 4, 2017
A Sensitive in Vitro High-Throughput Screen To Identify Pan-filoviral Replication Inhibitors Targeting the VP35-NP Interface
Gai Liu, Peter J Nash, Britney Johnson, et al.
Nature Communications
|
July 2, 2025
Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses
Michelle Meyer, Bronwyn M Gunn, Colette Pietzsch, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 24, 2020
Discovery of Marburg virus neutralizing antibodies from virus-naïve human antibody repertoires using large-scale structural predictions
Nina G Bozhanova, Amandeep K Sangha, Alexander M Sevy, et al.
Journal of Virology
|
February 5, 2010
Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells
James A Harker, Alexandra Godlee, Jennifer L Wahlsten, et al.
NPJ Vaccines
|
July 23, 2021
A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19
Delphine C Malherbe, Drishya Kurup, Christoph Wirblich, et al.
Page
of 17